Brief: Innoviva Q3 EPS USD 0.98
01/11/2023 20:15
Nov 01 (Reuters) - Innoviva Q3 pretax profit USD 85.952 million. * Q3 royalty revenue USD 53.558 million * Q3 net income USD 82.046 million * Q3 basic EPS USD 1.26
Recent news on Innoviva
See all newsInnoviva, Inc. reports results for the quarter ended June 30 - Earnings Summary
Innoviva Q2 revenue rises on higher net product sales
Brief: Innoviva Q2 Royalty Revenue USD 56.334 Million
Brief: Nortiva Bio Launches To Develop Long-Acting Oral Medicines
Brief: Innoviva Q1 Royalty Revenue USD 55.167 Million